SCHEMBL2824852

SCHEMBL2824852

O=C(CCO)OC(=O)CCO

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
TSHR P16473 2/20 0.35
CAMK2A Q9UQM7 1/20 0.33
PRSS1 P07477 1/20 0.32
CTSG P08311 1/20 0.32
CTRB1 P17538 1/20 0.32
CMA1 P23946 1/20 0.32
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
GPR84 Q9NQS5 1/20 0.30
FFAR1 O14842 1/20 0.30
FFAR4 Q5NUL3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10524175 0.88 ALDH1A1 (0.57) ALDH1A1TSHRMGAMGAASI
SCHEMBL2127555 0.86 ALDH1A1 (0.79) ALDH1A1TSHRMGAMGAASI
SCHEMBL1705352 0.84
SCHEMBL2124442 0.82
SCHEMBL2671031 0.80 CAMK2A (0.50) ALDH1A1TSHRCAMK2APRSS1CTSG
SCHEMBL28329752 0.80 ALDH1A1 (0.45) ALDH1A1TSHRMGAMGAASI
SCHEMBL28282954 0.80 ALDH1A1 (0.45) ALDH1A1TSHRMGAMGAASI
SCHEMBL27973065 0.80 ALDH1A1 (0.45) ALDH1A1TSHRMGAMGAASI
SCHEMBL12752041 0.80
SCHEMBL28645471 0.79 TSHR (0.35) ALDH1A1TSHRCAMK2AMGAMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112961392-B Preparation method of bionic layered material based on microbial mineralization 西南科技大学 2022-08-12 CN claimed
CN-112961392-A Preparation method of bionic layered material based on microbial mineralization 西南科技大学 2021-06-15 CN claimed
US-9505697-B2 Method for the production of acrylic acid or its derivatives THE PROCTER & GAMBLE COMPANY (US) 2016-11-29 US claimed
EP-2029514-B1 PRODUCTION OF ACETIC ACID AND MIXTURES OF ACETIC ACID AND ACETIC ANHYDRIDE EASTMAN CHEM CO (US) 2014-10-01 EP claimed
CN-101466659-B Production of acetic acid and mixtures of acetic acid and acetic anhydride EASTMAN CHEM CO 2013-09-25 CN claimed
US-7737298-B2 Production of acetic acid and mixtures of acetic acid and acetic anhydride EASTMAN CHEMICAL COMPANY (US) 2010-06-15 US claimed
CN-101466659-A Production of acetic acid and mixtures of acetic acid and acetic anhydride EASTMAN CHEM CO (US) 2009-06-24 CN claimed
EP-2029514-A2 PRODUCTION OF ACETIC ACID AND MIXTURES OF ACETIC ACID AND ACETIC ANHYDRIDE Eastman Chemical Company (US) 2009-03-04 EP claimed
WO-2007145795-A2 PRODUCTION OF ACETIC ACID AND MIXTURES OF ACETIC ACID AND ACETIC ANHYDRIDE EASTMAN CHEMICAL COMPANY (US) 2007-12-21 WO claimed
US-20070287862-A1 PRODUCTION OF ACETIC ACID AND MIXTURES OF ACETIC ACID AND ACETIC ANHYDRIDE EASTMAN CHEMICAL COMPANY (US) 2007-12-13 US claimed
US-20070219391-A1 dehydrating a beta -hydroxy carbonyl compound salt in a non-aqueous state at a preselected conversion temperature to produce a product salt selected from the group consisting of acrylate salts, polymer salts thereof, at a yield that exceeds an aqueous equilibrium-controlled maximum BATTELLE MEMORIAL INSTITUTE (US) 2007-09-20 US claimed
US-6218471-B1 REACTION PRODUCT WITH A POLYISOCYANATE ELF ATOCHEM S. A. (FR) 2001-04-17 US claimed
EP-3934707-B1 BIODEGRADABLE MESH IMPLANT FOR SOFT TISSUE REPAIR, IN PARTICULAR HERNIA REPAIR BAER HANS ULRICH (CH) 2023-01-18 EP disclosed
CN-112961392-B Preparation method of bionic layered material based on microbial mineralization 西南科技大学 2022-08-12 CN disclosed
CN-113125484-B Micro-nano layered space microbial mineralization and analysis method of action mechanism thereof 西南科技大学 2022-05-24 CN disclosed
US-20220143274-A1 Biodegradable Mesh Implant for Soft Tissue Repair BAER HANS ULRICH (CH) 2022-05-12 US disclosed
WO-1990008778-A1 HUMAN DERIVED MONOCYTE ATTRACTING PURIFIED PEPTIDE PRODUCTS USEFUL IN A METHOD OF TREATING INFECTION AND NEOPLASMS IN A HUMAN BODY THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) 1990-08-09 WO disclosed
WO-1990008777-A1 HUMAN DERIVED MONOCYTE ATTRACTING PURIFIED PROTEIN PRODUCT USEFUL IN A METHOD OF TREATING INFECTION AND NEOPLASM IN HUMAN BODY, AND THE CLONING OF FULL LENGTH cDNA THEREOF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) 1990-08-09 WO disclosed
EP-0255717-A2 Ganglioside related compounds and method of producing the same MECT CORPORATION (JP) 1988-02-10 EP disclosed
US-4686193-A SYNTHETIC ANTIGENS, GLYCOLIPIDS OR IMMUNO-ADSORBENTS WHEN BONDED TO A CARRIER BEHRINGWERKE AKTIENGESELLSCHAFT (DE) 1987-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219391-A1 dehydrating a beta -hydroxy carbonyl compound salt in a non-aqueous state at a preselected conversion temperature to produce a product salt selected from the group consisting of acrylate salts, polymer salts thereof, at a yield that exceeds an aqueous equilibrium-controlled maximum SORD, EBP, DHCR24 ALDH1A1 158/4885TSHR 4788/4885CAMK2A 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.